Adverse effects of corticosteroids: II. systemic

Clinics in Dermatology

Volumn 4, Issue 1, 1986, Pages 161-169

  Davis, Gerald F ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID;

ADULT; BONE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; DIGESTIVE SYSTEM DISEASE; DRUG ERUPTION; ENDOCRINE DISEASE; EYE DISEASE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IATROGENIC DISEASE; IMMUNOPATHOLOGY; MALE; METABOLIC DISORDER; MUSCLE DISEASE; PREGNANCY; REVIEW;

ADRENAL CORTEX HORMONES; ADULT; BONE DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DIGESTIVE SYSTEM DISEASES; DRUG ERUPTIONS; ENDOCRINE DISEASES; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HEMATOLOGIC DISEASES; HUMAN; IMMUNOLOGIC DISEASES; MALE; METABOLIC DISEASES; MUSCULAR DISEASES; PREGNANCY;

EID: 0022436037     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(86)90020-9     Document Type: Article

References (47)

1. Effects of glucocorticoids on cultured skin fibroblasts and keratinocytes
2. Adrenal glucocorticoids after twenty years—A review of their clinically relevant consequences
3. Inhibition of collagen accumulation in fibrotic process review of pharmacologic agents and new approaches with amino acids and their analogues
4. Single daily dose prednisone therapy
5. Pseudomorphea: a side effect of subcutaneous corticosteroid injection
6. Prednisone therapy for alopecia areata
7. Transepidermal elimination of altered collagen after intralesional adrenal steroid injections
8. Spontaneous skin tearing during systemic corticosteroid treatment
9. Alternative day prednisone therapy: evaluation of delayed hypersensitivity responses, control of disease and steroid side effects
10. Perilymphatic atrophy of the skin
11. Systemic steroid therapy with intramuscular triamcinolone
12. Cutaneous changes produced by prolonged systemic steroid therapy
13. Local skin rash after intra-articular methyl prednisolone acetate injection in a patient with rheumatoid arthritis
14. Use and abuse of systemic steroid therapy
15. Clinical complications of corticosteroid therapy
16. Posterior subcapsular cataracts related to long-term corticosteroid treatment in children
17. Development of posterior subcapsular cataracts in asthmatic children
18. Atopic cataracts versus steroid cataracts
19. Cataracts after short-term corticosteroid treatment
20. Posterior subcapsular cataracts in steroid-requiring asthmatic children
21. Cutaneous corticosteroid injection and amaurosis
22. Tissue effects of glucocorticoids
23. Ulcerogenic potential of glucocorticoids and possible prophylactic measures
24. Nonassociation of adrenocorticoid therapy and peptic ulcer
25. Acute pancreatitis associated with steroid therapy
26. Dexamethasone myopathy
27. Steroid myopathy in connective tissue disease
28. Muscle wasting and corticosteroid therapy
29. Complications of steroid therapy
30. Systemic corticosteroid therapy: pharmacology and endocrinologic considerations
31. Cortisone induced osteoporosis
32. Aseptic bone necrosis and corticosteroid therapy
33. Steroid-induced osteonecrosis: a review
34. The etiology of steroid-induced avascular necrosis of bone. A laboratory and clinical study
35. Fat embolism as a possible mechanism of producing avascular necrosis
36. Systemic use of corticosteroids in dermatology. Part I. Basic aspects
37. Glucocorticoid therapy: mechanism of action and clinical considerations
38. Activation of pulmonary tuberculosis following intralesional corticosteroid
39. Prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population
40. Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide
41. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function
42. Clinical significance of pituitary-adrenal suppression by exogenous corticosteroids
43. Oral vs. parenteral corticosteroids: a clinical controversy
44. Growth suppression in asthmatic children receiving prolonged therapy with prednisone and methylprednisone